<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>ABO incompatible allogeneic bone marrow transplants can be performed successfully to treat patients with <z:hpo ids='HP_0001909'>leukemia</z:hpo> or <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>These transplants carry no great risk of rejection or <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e>, however, some method must be used to avoid <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0010163'>hemolysis</z:mp> at the time of infusion of ABO incompatible marrow </plain></SENT>
<SENT sid="2" pm="."><plain>We have used successfully large volume plasma exchange to remove anti-A or anti-B antibodies prior to marrow infusion </plain></SENT>
<SENT sid="3" pm="."><plain>More recently we have used immunoadsorbent columns containing synthetic A or B antigen specifically to remove anti-A or anti-B antibodies in lieu of plasma exchange </plain></SENT>
<SENT sid="4" pm="."><plain>These columns are better tolerated than plasma exchange where allergic reactions are common </plain></SENT>
</text></document>